Characterization of human involucrin promoter distal regulatory region transcriptional activator elements-a role for Sp1 and AP1 binding sites
about
Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessingThe human involucrin gene contains spatially distinct regulatory elements that regulate expression during early versus late epidermal differentiationLoricrin expression in cultured human keratinocytes is controlled by a complex interplay between transcription factors of the Sp1, CREB, AP1, and AP2 familiesApigenin inhibition of involucrin gene expression is associated with a specific reduction in phosphorylation of protein kinase Cdelta Tyr311The distal regulatory region of the human involucrin promoter is required for expression in epidermisCharacterization of the MN/CA 9 promoter proximal region: a role for specificity protein (SP) and activator protein 1 (AP1) factorsFarnesol stimulates differentiation in epidermal keratinocytes via PPARalphaSuppression of AP1 transcription factor function in keratinocyte suppresses differentiationCloning and characterization of the human protein kinase C-eta promoter.The human immunodeficiency virus type 1 Tat protein up-regulates the promoter activity of the beta-chemokine monocyte chemoattractant protein 1 in the human astrocytoma cell line U-87 MG: role of SP-1, AP-1, and NF-kappaB consensus sites.Induction of disease-associated keratin 16 gene expression by epidermal growth factor is regulated through cooperation of transcription factors Sp1 and c-Jun.Comprehensive human transcription factor binding site map for combinatory binding motifs discovery.Protein kinase C (PKC) delta suppresses keratinocyte proliferation by increasing p21(Cip1) level by a KLF4 transcription factor-dependent mechanism.Protein arginine methyltransferase 5 (PRMT5) signaling suppresses protein kinase Cδ- and p38δ-dependent signaling and keratinocyte differentiation.Methylosome Protein 50 and PKCδ/p38δ Protein Signaling Control Keratinocyte Proliferation via Opposing Effects on p21Cip1 Gene ExpressionSulforaphane induction of p21(Cip1) cyclin-dependent kinase inhibitor expression requires p53 and Sp1 transcription factors and is p53-dependent.Opposing action of curcumin and green tea polyphenol in human keratinocytes.Keratinocyte proliferation, differentiation, and apoptosis--differential mechanisms of regulation by curcumin, EGCG and apigenin.Protein kinase C δ increases Kruppel-like factor 4 protein, which drives involucrin gene transcription in differentiating keratinocytes.Sp1 and AP-1 regulate expression of the human gene VIL2 in esophageal carcinoma cells.Synergistic activation of human involucrin gene expression by Fra-1 and p300--evidence for the presence of a multiprotein complex.Shear stress inhibits homocysteine-induced stromal cell-derived factor-1 expression in endothelial cells.Inhibitory role of TGIF in the As2O3-regulated p21 WAF1/CIP1 expression.Thapsigargin suppresses phorbol ester-dependent human involucrin promoter activity by suppressing CCAAT-enhancer-binding protein alpha (C/EBPalpha) DNA binding.Regulation of the transglutaminase I gene. Identification of DNA elements involved in its transcriptional control in tracheobronchial epithelial cells.Promoter identification and transcriptional regulation of the metastasis gene MACC1 in colorectal cancer.The combination of ubiquitous transcription factors AP-1 and Sp1 directs keratinocyte-specific and differentiation-specific gene expression in vitro.Regulation of the human involucrin gene promoter by co-activator proteins.CCAAT/enhancer-binding proteins. A role in regulation of human involucrin promoter response to phorbol ester.Transcription factor Sp1 activates involucrin promoter activity in non-epithelial cell types.Identification of an involucrin promoter transcriptional response element with activity restricted to keratinocytesAP1 transcription factors in epidermal differentiation and skin cancerAP1 factor inactivation in the suprabasal epidermis causes increased epidermal hyperproliferation and hyperkeratosis but reduced carcinogen-dependent tumor formationMEP50/PRMT5 Reduces Gene Expression by Histone Arginine Methylation and this Is Reversed by PKCδ/p38δ Signaling.MEK6 regulates human involucrin gene expression via a p38alpha - and p38delta -dependent mechanism.Green tea polyphenol and curcumin inversely regulate human involucrin promoter activity via opposing effects on CCAAT/enhancer-binding protein function.Targeting of Sp1 transcription factor: a novel therapeutic approach for keloids, an in vitro analysis.Regulation of forestomach-specific expression of the murine adenosine deaminase gene.Human Keratinocyte Differentiation Requires Translational Control by the eIF2α Kinase GCN2.
P2860
Q24300787-778A2EED-8CDC-4DFC-BD17-124AEEA7FAF3Q28202057-7DECC23E-A48B-4395-B959-C1FFAC739B46Q28219317-20ACD649-61EE-4EC6-AEF8-42646AC88DF7Q28264259-9798B8C0-DFBA-4813-98DD-9F78C2DF2757Q28287929-95FF91E4-AF00-4732-8472-B5478E4D6C81Q28362417-91283311-EE7B-44F6-99A5-6CB063C1E7A3Q28375920-AE1D8CC3-D789-47FB-B21E-15BAB503A776Q28729714-EBF98942-DB3A-4449-B7B1-AB02CC6AEEFEQ30778600-EE10D466-0360-4CD8-BBDD-249CC89696EFQ33797102-BBA970EF-C6C4-4296-9BF0-84F775F948EBQ34227736-FC46F646-746F-4E59-B371-02DF137E551DQ34499593-89A1128D-38AA-49DD-9A5D-5E3D8BC93297Q35309397-E865048D-B19F-4E8C-92FD-632B9ED7A778Q35801889-FD33ECE2-4D60-4072-B7ED-00D84D3720EDQ35861025-AF1AF348-BD98-470F-8511-864A1836499CQ35956502-483842BD-CE90-48F1-AE3B-31E73661A3F1Q36365203-716CAF21-A3EA-4BC0-96E2-697ECA100825Q36817539-8BD4D54B-62C0-4CB2-A9F5-92ED5B68DA4EQ36929105-36F9069C-AD89-4207-8FC5-D18615509337Q37134443-BF338E40-C41C-4639-88BD-BA65EED7CC49Q37157320-6FC0D5DB-64DE-4461-83B2-222351B96171Q37407437-307543E5-A2FE-4435-9E4E-B0E989F87739Q38294353-B859B684-0A36-4BA9-B85D-39AA2280C0FBQ38308713-5565E557-3B75-424D-A09F-D0FBDCEB0DE1Q38328973-63416DE3-270C-49F8-9A2D-118363639D92Q39135113-FF3ECA40-2437-45CB-8FEF-8BBECAB5E0A5Q40183429-5E4E82CD-0BD0-4C35-ADCF-1EC66726D308Q40577860-DFBC7661-BF3A-4063-A89A-275E68F759B2Q40970962-8AF1BB30-165C-454E-8F2C-AE7657B06B73Q40979165-5BCF0506-2085-46F8-A18B-0CF33F7DCF6DQ41733865-F86F2FCB-FC95-4CEB-A327-FA8E5E8B47E8Q41878046-059D2441-719C-43CF-87FF-B9BC22B40F38Q42201057-28F20A38-AF6A-4837-A784-E5FC845167ACQ42736264-5AAA9503-9D27-455B-A763-00AD30376123Q43675449-95F5815B-1B4F-4D36-9B7D-7CF11F044990Q44814586-0669E326-C6D2-4EB9-8B4F-10A836F4DEAEQ46887392-9F010B77-A24E-4243-BF4E-94D2F6E202A3Q47975127-6DB0FE72-0239-49B4-8057-3699DACF530EQ50990310-8711E346-A463-474F-A8D1-D82CCD5D5350
P2860
Characterization of human involucrin promoter distal regulatory region transcriptional activator elements-a role for Sp1 and AP1 binding sites
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Characterization of human invo ...... for Sp1 and AP1 binding sites
@ast
Characterization of human invo ...... for Sp1 and AP1 binding sites
@en
Characterization of human invo ...... for Sp1 and AP1 binding sites
@en-gb
Characterization of human invo ...... for Sp1 and AP1 binding sites
@nl
type
label
Characterization of human invo ...... for Sp1 and AP1 binding sites
@ast
Characterization of human invo ...... for Sp1 and AP1 binding sites
@en
Characterization of human invo ...... for Sp1 and AP1 binding sites
@en-gb
Characterization of human invo ...... for Sp1 and AP1 binding sites
@nl
prefLabel
Characterization of human invo ...... for Sp1 and AP1 binding sites
@ast
Characterization of human invo ...... for Sp1 and AP1 binding sites
@en
Characterization of human invo ...... for Sp1 and AP1 binding sites
@en-gb
Characterization of human invo ...... for Sp1 and AP1 binding sites
@nl
P2093
P2860
P356
P1433
P1476
Characterization of human invo ...... for Sp1 and AP1 binding sites
@en
P2093
P2860
P356
10.1042/BJ3310061
P407
P478
331 ( Pt 1)
P577
1998-04-01T00:00:00Z